Rhenu Bhuller
One of her key areas of focus is technology and the impact this is having on various industries and business models as companies are impacted by these megatrends and developments globally and need to transform to stay relevant for the future.
She works with Frost & Sullivan’s analysts on the impact of cutting-edge technologies such as robotics and automation, big data analytics, AI and Blockchain on major industries as well as how market trends and disruptive technologies are impacting business models and the future of healthcare delivery.
Articles: Rhenu Bhuller
The Technology Driving Rare Disease Pipelines
Opinion / Rhenu Buller, an expert on disruptive technologies at business consultancy Frost & Sullivan’s Asia Pacific office, outlines the technological innovations currently driving the drug development pipelines of rare disease companies. Recent advancements in the development of novel platforms for precise targeting of small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification…
Beyond the Pill — Pharma Takes a Stake In Digital Health
Digital Health / Rhenu Bhuller, a founding member of Frost & Sullivan’s Asia Pacific operations and expert in analysing the impact of cutting-edge tech, looks at pharma’s evolution and adoption of digital health. The evolution of disease management and the convergence of drugs, devices and digital health in the management of various conditions now require pharmaceutical companies…
Latest Report
